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impact on diagnostic yield
Abstract
Introduction: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is the standard diagnostic method 
for sampling mediastinal and hilar lymph nodes. Non-diagnostic samples have led some pulmonologists to add a miniforceps 
biopsy (EBUS-TBFB) in order to increase diagnostic yield. Our study aims to analyze the impact of adding EBUS-TBFB to the 
EBUS-TBNA in cases where Rapid On-site Evaluation (ROSE) was negative for malignancy or was non-diagnostic.
Material and methods: This retrospective chart review included 91 patients who were aged 18–90 years old and underwent 
EBUS with both TBNA and TBFB between January 1, 2013 and July 1, 2018.
Results: There was no significant statistical difference in the diagnostic yield of TBNA vs TBFB with a McNemar value of 0.167, 
and this conclusion was the same when stratified by race, age and lymph node size. Using TBNA as a gold standard, the sensi-
tivity and specificity of TBFB was 87% and 69%, respectively. Out of the non-diagnostic TBNA samples on ROSE and cell-block, 
subsequent TBFB resulted in additional pathologic diagnoses in 16% of cases, of which 67% were non-caseating granulomas. 
Furthermore, two additional malignant cases were identified by TBFB consisting of small cell carcinoma and non-Hodgkin’s 
lymphoma.
Conclusion: In conclusion, TBFB is a useful adjunctive tool in the diagnosis of non-malignant conditions (i.e. granulomatous dis-
eases) with the potential to spare the patient from more invasive surgical biopsies. Training of future fellows in performing TBFB 
in addition to TBNA should be strongly encouraged.
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Introduction
Since its introduction in 1983 [1, 2], trans-
bronchial needle aspiration (TBNA) has been 
a minimally invasive procedure for the sampling 
of mediastinal lymph nodes using bronchoscopy. 
However, the TBNA technique, in its infancy, was 
underutilized by clinicians because of its “blind” 
nature without direct real time visualization. In 
2002, with the introduction of the convex probe 
endobronchial ultrasound (CP-EBUS), clinicians 
were finally able to perform real-time endobron-
chial visualization for TBNA. By 2007, EBUS-TB-
NA had become the routine method utilized by 
pulmonologists for the sampling of mediastinal 
and hilar lymph nodes [1–3].
The diagnostic yield of EBUS-TBNA varies 
greatly based on pathology. High yields have par-
ticularly been seen in the staging and diagnosis 
of non-small cell lung cancer (NSCLC) [1, 4–7].
Diagnostics yield for mediastinal lymphade-
nopathy in conditions such as lymphoma and 
granulomatous disease, however, remain under 
investigation. With regard to sarcoidosis, results 
are divided, with some reports of obtaining 
sufficient tissue for analysis, while others fre-
quently resort to more invasive techniques such 
as mediastinoscopy for diagnosis [6, 8, 9].  The 
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underlying reason for such variance in samples 
have been associated with the low tissue sample 
volume that is obtainable while using the stan-
dard 20–22–gauge needles for EBUS-TBNA.
The introduction of an additional biopsy 
using miniforceps (EBUS-TBFB) has been used 
to attempt to increase yield. Sample acquisition 
is performed through the initial hole made by the 
TBNA needle for obtaining diagnostic material 
from enlarged lymph nodes [6, 10–12]. Recent 
studies using TBFB for lymphadenopathy have 
shown improved yields; however, these studies 
have had their limitations that included lack of 
EBUS guidance, use of initial TBNA puncture site 
prior to performing TBFB, and/or Rapid On-site 
Evaluation (ROSE).
The use of the initial TBNA site as the en-
trance point for TBFB along with ROSE for both 
TBNA and TBFB sampling has been previously 
described to improve diagnostic yields with 
varying degrees of success. Our study aimed to 
analyze the impact of adding EBUS-TBFB to the 
EBUS-TBNA in cases where ROSE was deemed 
negative for malignancy or was non-diagnostic.
Material and methods
Data collection and patient inclusion
This study is a retrospective chart review of 
patients who underwent EBUS with both minifor-
ceps biopsy and fine needle aspiration. Patients 
were eligible for analysis within age ranges of 
18 to 90 years who had an EBUS procedure during 
the period from January 1, 2013 to July 2018. Data 
were collected only from those patients who 
underwent both EBUS-TBFB and EBUS-TBNA.
Exclusion criteria included any patient who 
had a diagnosis of cancer established with other 
testing modalities and any patient who did not 
have both EBUS with TBNA and miniforceps 
biopsy. Patients eligible for the chart review were 
identified from billing data. Data were collected 
by chart review from the electronic medical re-
cord eCare®. 
Statistical analysis
Descriptive statistics were generated to char-
acterize the study group. Categorical variables, 
such as sex, were described using frequency 
distributions. Continuous variables were de-
scribed as the mean with standard deviation for 
normally distributed variables, and mode with an 
interquartile range for non-normally distributed 
variables. Sensitivity, specificity, positive predic-
tive value, and negative predictive value were 
computed. Univariable analysis was done using 
the chi-squared test, Student’s t-test, and analysis 
of variance. Multivariable regression was done 
using logistic regression. The diagnostic yields 
of EBUS-TBNA and a combined approach with 
EBUS-TBNA and EBUS-TBFB were compared 
with the McNemar test for dependent samples. p 
< 0.05 was considered statistically significant. All 
data were analyzed using SPSS v. 25.0, and a p-val-
ue of 0.05 or less indicated statistical significance.
This study was approved by the Ascension 
St. John Hospital Institutional Review Board.
Endobronchial ultrasound-guided 
transbronchial needle aspiration
A real-time EBUS scope (Model: Olympus BF-
UC180F, Japan) was used in all cases. The EBUS 
scope uses a 6.9 mm outer diameter, a 2.0 mm 
working channel, and 30-degree oblique for-
ward-viewing scope. A linear 7.5hz ultrasound 
transducer with 50 mm penetration capability was 
used for the visualization of each lymph node.
TBNA was performed using a 21-guage nee-
dle (Model: Olympus ViziShot EBUS-TBNA 
NA-201SX-4022, Japan). If visualization of ad-
jacent vasculature was needed during TBNA, 
an integrated color Doppler US was utilized on 
a case-by-case basis under the discretion of the 
interventional pulmonologist. A minimum of 3 to 
5 passes were performed at each station.
Endobronchial ultrasound-guided 
transbronchial forceps biopsy
For all TBFB biopsies, Boston Scientific “Spy-
Bite biopsy” Forceps (Model: M00546270 USA) 
were used. After obtaining an EBUS-TBNA sample 
which was found to be non-diagnostic on initial 
ROSE, the sampled lymph node was evaluated by 
EBUS-TBFB. Our method of EBUS-TBFB for each 
sample was similar to that which had been previ-
ously described by Chrissian et al. [10]. While at 
the TBNA site, and after obtaining a sample via 
the jabbing technique, forceps were advanced to 
the orifice of the TBNA puncture site by direct vi-
sualization and confirmed via ultrasound (Figures 
1, 2). When visualization of the puncture site was 
limited, an approximation of the initial angle of 
TBNA sampling was performed under ultrasound 
(Figure 2). Closed forceps were advanced into the 
lymph node through the initial puncture site at 
the same angle as our TBNA. The forceps were 
subsequently opened and advanced to obtain 
a sample against tissue resistance under con-
tinuous EBUS surveillance. Finally, the forceps 
were closed and withdrawn through the working 
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channel. In patients in whom TBNA or TBFB was 
unrevealing, the diagnosis was confirmed through 
surgical biopsy specimens of the mediastinum via 
mediastinoscopy, video-assisted thoracic surgery 
(VATS), or via a follow-up computerized tomog-
raphy (CT) scan of the thorax.
Rapid on-site analysis
Fine needle aspiration samples obtained 
by TBNA were transferred onto glass slides, air 
dried, and subsequently mounted by the on-site 
pathologist. Rapid on-site cytology was performed 
and each of the three TBNA samples were pro-
cessed individually by the on-site pathologist. 
TBFB samples were obtained only when TBNA 
samples were deemed non-diagnostic on initial 
ROSE. Tissue samples which were obtained from 
TBFB were placed in formalin immediately after 
acquisition. For TBNA samples, the Diff-Quick 
(Diff-Quik) Staining Protocol and light micros-
copy was performed by board certified on-site 
cytopathologists. Samples were subsequently sent 
for cell block analysis after ROSE was completed.
Post-operative monitoring
All patients were observed in the post-oper-
ative monitoring unit for 2 hours after the proce-
dure. All patients with concerning post-procedur-
Figure 1. Direct visualization of the initial transbronchial needle aspira-
tion puncture site prior to transbronchial forceps biopsy
Figure 2. Correct angling of forceps within the lymph node. A. The original angle of  transbronchial needle aspiration (TBNA); B. Angling of the 
transbronchial forceps biopsy to approximate the same approach as our initial TBNA with the forceps in an open position
A
B
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al symptoms (i.e. chest pain, dyspnea, hemoptysis, 
or persistent tachycardia) underwent chest X-ray.
Results
The study group consisted of 91 patients 
who met the inclusion criteria. The mean age of 
patients in the study at the time of procedure was 
57 ± 12.31 years old. 51.5% (47) were male and 
58.2% were white (53). The mean BMI of patients 
was 28.2 ± 7.27. Subsequent lymph node biopsies 
were performed at stations shown in (Table 1) by 
the interventional pulmonologist with the most fre-
quent locations being subcarinal (station 7), lower 
paratracheal (station 4), and interlobar (station 11). 
The mean lymph node size per CT imaging was 
28.5 mm with a range from 6.0 to 90.0 mm.
ROSE was diagnostic of the final pathology in 
39 cases (42.9%). There was no significant statis-
tical difference in the diagnostic yield of TBNA vs 
TBFB with a McNemar value of 0.115. This con-
clusion was the same when stratified by age and 
size of lymph nodes with respective t-test values 
of 0.954, 0.651, and 0.139, as well as by gender 
and race with respective chi-square values of 
0.923 and 0.280. Using TBNA as a gold standard, 
the sensitivity and specificity of TBFB was 87% 
(confidence interval of 73.74% to 95.06%) and 
69% (confidence interval of 53.35% to 81.83%), 
respectively. Out of non-diagnostic TBNA sam-
ples on ROSE and cell-block, subsequent TBFB 
sampling resulted in additional pathologic di-
agnoses in 16% of cases, of which 67% were 
non-caseating granulomas. Furthermore, two 
additional malignant cases were identified via 
TBFB which were not diagnosed on TBNA. These 
consisted of small cell carcinoma and non-Hod-
gkin’s lymphoma.
Complications
No clinical complications were observed during 
EBUS-TBNA, EBUS-TBFB, or induction of anesthe-
sia. All patients with concerning post-procedural 
symptoms (i.e. chest pain, dyspnea, hemoptysis, 
or persistent tachycardia) underwent chest X-ray 
without any complications being reported.
Discussion
In our study, we investigated the clinical 
utility provided by the addition of EBUS-TBFB 
Table 1. Frequency of mediastinal and hilar lymph nodes 
examined by TBNA and TBFB
Station name Station no Frequency
Subcarinal 7 67




Upper paratracheal 2 2
TBNA —  transbronchial needle aspiration; TBFB — transbronchial forceps biopsy
Table 2. Diagnostic yield of EBUS-TBNA, EBUS-TBFB, and ROSE
EBUS-TBNA EBUS-TBFB Combined ROSE
Overall diagnostic yield 54/91 (59.3%) 46/91 (50.5%) 60/91 (65.9%) 39/91 (42.9%)
Malignant 29 29
Small cell cancer 9/11 9/11
NSCLC — total 20/20 11/20
Squamous cell cancer 5/5 4/5
Adenocarcinoma 14/14 6/14




EBUS-TBFB vs EBUS-TBNA using the McNemar test
Combined vs EBUS-TBNA using the McNemar test
*Other: final diagnosis showing Seminoma, Mycobacterium tuberculosis, Lymphangioma, and bronchus-associated lymphoid tissue. EBUS-TBNA — endobronchial 
ultrasound-guided transbronchial needle aspiration; EBUS-TBFB — endobronchial ultrasound-guided transbronchial forceps biopsy; NSCLC — non-small-cell lung 
carcinoma; ROSE — Rapid On-site Evaluation 
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to TBNA for obtaining the primary diagnosis 
and for sampling mediastinal and hilar lymph 
nodes. In the past, many patients underwent more 
invasive surgical biopsies via mediastinoscopy 
as the first line diagnostic modality. However, 
after the advent of EBUS-TBNA and many subse-
quent investigations of its utility, it has become 
the standard as a minimally invasive modality 
for evaluating concerning hilar and mediastinal 
lymph nodes. The sensitivity of EBUS-TBNA for 
diagnosing and staging NSCLC and SCC has been 
reported to be approximately between 84–94% 
[5, 6, 13–15]. In our study, the diagnostic yield 
achieved by EBUS-TBNA for NSCLC and SCLC 
were 100% (20/20) and 81% (9/11), respectively.
However, in granulomatous disease and lym-
phoma, EBUS-TBNA yield had been varied and, 
once again, many patients required the utilization 
of mediastinoscopy in order to obtain larger tis-
sues samples than obtainable by TBNA [6, 8, 9]. 
Thus, in our study we have utilized EBUS-TBNA 
results on ROSE to examine the additive yield 
provided by the EBUS-TBFB especially in granu-
lomatous diseases such as sarcoidosis. The diag-
nostic yield for Sarcoidosis within our study was 
83% (19/23) which is higher than those reported 
in previous studies showing approximately 61% 
[16]. This, in turn, is likely multifactorial and can 
be affected by population prevalence, operator 
skill, and sample sizes obtained. Furthermore, 
the diagnostic yield of TBFB in our study was 
96% (22/23), which is again higher than the 
previous value reported by Darwiche et al. [16] 
of approximately 89%. Finally, using TBNA as 
a gold standard, the sensitivity and specificity 
of EBUS-TBFB was 87% and 69%, respectively.
In this study, we have demonstrated that 
EBUS-TBFB appears to be safe. We had no sig-
nificant bleeding, mediastinitis, pneumotho-
rax, or intraprocedural death. Post-procedural 
chest X-rays were performed in patients with 
concerning symptoms (i.e. chest pain, dyspnea, 
hemoptysis, or persistent tachycardia) without 
any complications being reported. 
In addition to its larger sample size and uti-
lization of ROSE in each patient’s sampling to 
ensure adequate sample volume acquisition, our 
study also utilized standard EBUS tools for both 
TBNA and TBFB. This allowed for easy replica-
tion and integration into current practice. This 
differs from previous studies which had utilized 
proprietary developed forceps with sharpened 
edges for easier penetration of the bronchial 
wall. Our study was also a single operator study 
as this procedure is very technique-dependent. 
As a result, the conclusions of this paper would 
Figure 3. Flow chart illustrating the review, exclusion, and analysis of 459 patients who were initially selected, 91 of whom were eligible for analysis. 
VATS — video-assisted thoracic surgery; TBNA —  transbronchial needle aspiration; TBFB — transbronchial forceps biopsy
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be stronger if it showcased results from multiple 
operators and multiple centers.
In conclusion, TBFB is a useful adjunctive 
tool in the diagnosis of non-malignant condi-
tions such as granulomatous diseases with the 
potential to spare the patient from undergoing 
more invasive surgical biopsies. This approach 
is shown to be safe without increasing compli-
cation rates. Furthermore, in the current age of 
individualized targeted therapy for lung cancer, 
the additional tissue sample volume provided by 
TBFB may provide additional value to its incor-
poration into routine practice. Training of future 
fellows in performing TBFB in addition to TBNA 
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